Hansoh Pharmaceutical Group Dividends and Buybacks
Dividend criteria checks 0/6
Hansoh Pharmaceutical Group is a dividend paying company with a current yield of 1.41%. Next payment date is on 25th July, 2025 with an ex-dividend date of 3rd July, 2025.
Key information
1.4%
Dividend yield
0.0004%
Buyback Yield
| Total Shareholder Yield | 1.4% |
| Future Dividend Yield | 1.3% |
| Dividend Growth | 44.9% |
| Next dividend pay date | 25 Jul 25 |
| Ex dividend date | 03 Jul 25 |
| Dividend per share | n/a |
| Payout ratio | 43% |
Recent dividend and buyback updates
Recent updates
Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Shares Climb 31% But Its Business Is Yet to Catch Up
Mar 31
Calculating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Mar 23Do Hansoh Pharmaceutical Group's (HKG:3692) Earnings Warrant Your Attention?
Feb 10Hansoh Pharmaceutical Group Company Limited (HKG:3692) Investors Are Less Pessimistic Than Expected
Dec 27Hansoh Pharmaceutical Group Company Limited's (HKG:3692) Intrinsic Value Is Potentially 41% Above Its Share Price
Dec 10Hansoh Pharmaceutical Group (HKG:3692) Seems To Use Debt Rather Sparingly
Nov 21Is Now The Time To Put Hansoh Pharmaceutical Group (HKG:3692) On Your Watchlist?
Nov 04Estimating The Fair Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Aug 28Pinning Down Hansoh Pharmaceutical Group Company Limited's (HKG:3692) P/E Is Difficult Right Now
Aug 07If EPS Growth Is Important To You, Hansoh Pharmaceutical Group (HKG:3692) Presents An Opportunity
Jul 16Hansoh Pharmaceutical Group (HKG:3692) Could Easily Take On More Debt
Jun 24Hansoh Pharmaceutical Group Company Limited's (HKG:3692) CEO Will Probably Find It Hard To See A Huge Raise This Year
Jun 06Estimating The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)
May 23Upcoming Dividend Payment
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 3692 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are stable.
Growing Dividend: 3692 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are increasing.
Dividend Yield vs Market
| Hansoh Pharmaceutical Group Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (3692) | 1.4% |
| Market Bottom 25% (HK) | 3.0% |
| Market Top 25% (HK) | 7.8% |
| Industry Average (Pharmaceuticals) | 2.8% |
| Analyst forecast (3692) (up to 3 years) | 1.3% |
Notable Dividend: 3692's dividend (1.41%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (3.02%).
High Dividend: 3692's dividend (1.41%) is low compared to the top 25% of dividend payers in the Hong Kong market (7.82%).
Earnings Payout to Shareholders
Earnings Coverage: 3692 is not paying a notable dividend for the Hong Kong market.
Cash Payout to Shareholders
Cash Flow Coverage: 3692 is not paying a notable dividend for the Hong Kong market.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/07 19:59 |
| End of Day Share Price | 2025/05/07 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Hansoh Pharmaceutical Group Company Limited is covered by 34 analysts. 24 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Bo Li | BofA Global Research |
| Jin Zhang | China International Capital Corporation Limited |
| Ziyu He | China International Capital Corporation Limited |